We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$390M
AUM Growth
+$73M
Cap. Flow
+$37.6M
Cap. Flow %
9.65%
Top 10 Hldgs %
76.67%
Holding
31
New
3
Increased
11
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
LBRDK icon
Liberty Broadband Class C
LBRDK
+$113M
2
ARGX icon
argenx
ARGX
+$19.4M
3
EYPT icon
EyePoint Inc
EYPT
+$16.3M
4
TVTX icon
Travere Therapeutics
TVTX
+$1.8M
5
RVMD icon
Revolution Medicines
RVMD
+$1.78M

Top Sells

Rank Stock Value
1
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$29M
2
FOLD
Amicus Therapeutics
FOLD
+$21.1M
3
HPLTW
Home Plate Acquisition Corporation Warrant
HPLTW
+$20M
4
CYTK icon
Cytokinetics
CYTK
+$15M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 68.75%
2 Communication Services 27.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
26
DELISTED
Amicus Therapeutics
FOLD
– –
-1,489,025
Closed -$21.1M
SAVE
27
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
– –
-1,700,000
Closed -$27.9M
MORF
28
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-496,856
Closed -$14.3M
ROSS.WS
29
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
– –
-439,666
Closed -$24.6K
HPLTW
30
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
– –
-331,416
Closed -$20M
1
2

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Finepoint Capital held 31 positions worth $390M, up 23% from $317M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Finepoint Capital deployed $37.6M of net new capital in Q1 2024, opening 3 new positions and adding to 11 existing holdings. Its largest new stake was argenx: 50,000 shares worth $19.7M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 80% a quarter earlier, followed by Communication Services.

On the sell side, the largest reduction was MoonLake Immunotherapeutics, an estimated $29M trimmed.

  • Finepoint Capital's largest Q1 2024 buy was argenx: 50,000 shares worth $19.7M.
  • Finepoint Capital added most to Liberty Broadband Class C in Q1 2024, an estimated $113M increase.
  • Finepoint Capital's biggest Q1 2024 reduction was MoonLake Immunotherapeutics, cutting an estimated $29M.
  • Finepoint Capital fully exited Amicus Therapeutics in Q1 2024, selling an estimated $21.1M.
  • Finepoint Capital's ten largest holdings make up 77% of its $390M portfolio in Q1 2024.
  • Finepoint Capital opened 3 new positions and closed 5 in Q1 2024.
  • Finepoint Capital's portfolio value rose 23% quarter-over-quarter to $390M.

Based on Finepoint Capital's 13F filing for Q1 2024, filed 14 May 2024.